| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.02 |